AL-9
CAS No. 869218-90-6
AL-9( HCV inhibitor AL-9 )
Catalog No. M16312 CAS No. 869218-90-6
AL-9 is a small molecule HCV replication inhibitor with EC50 of 0.29 and 0.75 uM for genotype 1b and 2a.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 873 | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameAL-9
-
NoteResearch use only, not for human use.
-
Brief DescriptionAL-9 is a small molecule HCV replication inhibitor with EC50 of 0.29 and 0.75 uM for genotype 1b and 2a.
-
DescriptionAL-9 is a small molecule HCV replication inhibitor with EC50 of 0.29 and 0.75 uM for genotype 1b and 2a, inhibits purified PI4KIIIα with IC50 of 0.57 uM; inhibits HCV across different genotypes with activity in the sub-micromolar to low micromolar range in the absence of significant cytotoxic effects; inhibits PI4KIIIα also in living cells, while not appreciably affecting the activity of PI4KIIIβ, does not affect the level of PI4P in the Golgi membrane.
-
In Vitro——
-
In Vivo——
-
SynonymsHCV inhibitor AL-9
-
PathwayMicrobiology/Virology
-
TargetHCV
-
RecptorHCV
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number869218-90-6
-
Formula Weight402.454
-
Molecular FormulaC23H22N4O3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESOCC1=CC=C(C2=CC3=C(NC4=CC=C(N5CCOCC5)C=C4)N=CN=C3C=C2)O1
-
Chemical Name(5-(4-((4-morpholinophenyl)amino)quinazolin-6-yl)furan-2-yl)methanol
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Bianco A, et al. PLoS Pathog. 2012;8(3):e1002576.
2. MacLeod AM, et al. ACS Med Chem Lett. 2013 May 8;4(7):585-9.
molnova catalog
related products
-
Deleobuvir
Deleobuvir (BI-207127, BI207127) is a potent, selective HCV NS5B polymerase inhibitor with IC50 of 50 nM against GT-1 HCV polymerase activity.
-
Glecaprevir
Glecaprevir (ABT 493;A 1282576) is a novel HCV NS3/4A protease inhibitor with pan-genotypic activity, inhibits NS3/4A proteases from HCV genotypes 1-6 in vitro with IC50 of 3.5-11.3 nM.
-
Sofosbuvir
Sofosbuvir (PSI-7977, GS-7977) is a HCV NS5B polymerase inhibitor for the treatment of chronic hepatitis C virus (HCV) infection.
Cart
sales@molnova.com